Sphingosine 1-Phosphate Receptor Modulators are Effective in Patients With Moderately to Severely Active Ulcerative Colitis and a Prior Biologic Exposure: A Meta-Analysis of Randomized Controlled Trials

Clin Gastroenterol Hepatol. 2024 May;22(5):1139-1141.e3. doi: 10.1016/j.cgh.2023.10.015. Epub 2023 Oct 30.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Colitis, Ulcerative* / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic*
  • Sphingosine 1 Phosphate Receptor Modulators* / therapeutic use
  • Treatment Outcome

Substances

  • Sphingosine 1 Phosphate Receptor Modulators